Superworth

Sonoma Pharmaceuticals price to book ratio SNOA

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
0.8×
10-year median
1.0×
Against its 10-year history
35th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.1× to 5.1×
Peer median
1.0×

Sonoma Pharmaceuticals' price to book ratio is 0.8× as of Oct 23, 2026.

That is below its ten-year median of 1.0×, lower than on 65% of days in the last ten years.

Over that time it ranged from 0.1× in Nov 2023 to 5.1× in Feb 2017.

The median for 10 healthcare stocks of a similar size is 1.0×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.8×0.5×1.9×
20251.6×0.7×2.2×
20240.7×0.3×1.1×
20230.4×0.1×1.3×
20220.5×0.5×1.3×
20211.2×1.2×2.8×
20201.3×0.5×2.1×
20190.6×0.4×0.9×
20180.4×0.4×1.5×
20171.5×1.0×5.1×
20163.5×1.4×3.6×
20151.8×0.5×3.1×
20141.0×0.9×16.1×
201315.0×4.1×18.6×
201278.5×78.5×193×
2011104×87.2×111×

Against its peers

Companies in Healthcare nearest Sonoma Pharmaceuticals' size, closest first, today.

CompanyPrice to book ratio
SNOASonoma Pharmaceuticals0.8×
OXBROXBRIDGE RE HOLDINGS1.2×
EDUCEducational Development0.2×
GTIMGood Times Restaurants0.4×
MDRRMedalist Diversified0.6×
BCGBinah Capital0.9×
VIPVulcan Infrastructure & Powern/m
MXCMexco Energy1.0×
CKXCKX Lands1.0×
MSGMMotorsport Games5.8×
ATCHAtlasClear1.1×
Peer median1.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Sonoma Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.